Ryan D Drant's Net Worth

$572 Million

Who is Ryan D Drant?

Ryan D Drant has an estimated net worth of $572 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., OPOWER, INC., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, Echo Global Logistics, Inc., FOXHOLLOW TECHNOLOGIES, INC., FUSION-IO, INC., ARYx Therapeutics, Inc., PEPLIN INC, TriVascular Technologies, Inc., INNERWORKINGS INC, HYPERION THERAPEUTICS INC, SUPERNUS PHARMACEUTICALS INC, CHANNELADVISOR CORP, Groupon, Inc., Zosano Pharma Corp, Clovis Oncology, Inc., AMICUS THERAPEUTICS INC, BOX INC, Loxo Oncology, Inc., Dermira, Inc., CHAMPIONS ONCOLOGY, INC., TREVENA INC, ARDELYX, INC., GLYCOMIMETICS INC, Tracon Pharmaceuticals, Inc., Epizyme, Inc., SUNESIS PHARMACEUTICALS INC, Roka BioScience, Inc., Omthera Pharmaceuticals, Inc., Tableau Software Inc, CVENT INC, XOOM Corp, AUDIENCE INC, INTERLEUKIN GENETICS INC, and HEMOSENSE INC.

SEC CIK

Ryan D Drant's CIK is 0001302106

Past Insider Trading and Trends

2014 was Ryan D Drant's most active year for acquiring shares with 56 total transactions. Ryan D Drant's most active month to acquire stocks was the month of May. 2014 was Ryan D Drant's most active year for disposing of shares, totalling 68 transactions. Ryan D Drant's most active month to dispose stocks was the month of May. 2012 saw Ryan D Drant paying a total of $47,805,439.45 for 54,336,081 shares, this is the most they've acquired in one year. In 2015 Ryan D Drant cashed out on 12,788,047 shares for a total of $109,687,782.00, their largest year based on trade value.